<DOC>
	<DOCNO>NCT01886833</DOCNO>
	<brief_summary>Zambia recently introduce routine infant immunization rotavirus - important cause severe gastroenteritis diarrhoea mortality child . Although vaccine like Rotarix cost effective tool infectious disease , live oral vaccine less immunogenic efficacious develop world setting compare industrialized country . Reasons behind phenomenon well understood , may relate continue maternal antigen exposure high level maternal immunity pass foetus/newborn transplacentally and/or breast milk . Therefore , three arise hypothesis include : ( ) high-level rotavirus-specific maternal immunity ( form anti-rotavirus breast-milk IgA transplacental serum IgG ) major contributor fail seroconversion follow infant vaccination . ( ii ) Malnutrition negatively impact infant immunity increase risk post-vaccination rotavirus gastroenteritis . ( iii ) Introduction rotavirus vaccine alter molecular epidemiology circulate rotavirus strain detect vaccinated child present severe diarrhea . To address hypothesis , propose study recruit prospective cohort 420 mother-infant pair . These enrolled time vaccination follow four year . Baseline immunological status ascertain seroconversion rate determine month full immunization . Incident rotavirus gastroenteritis monitor vaccinated infant whenever episode diarrhoea occur ; surveillance , sero-strains rotavirus cause disease track four year period . Contributions HIV infection mother infant , vitamin A zinc deficiency , weight age Z-scores well mid upper arm circumference also assess . Knowledge gain study inform future interventional trial strategy improve rotavirus vaccine effectiveness develop world .</brief_summary>
	<brief_title>Causes Rotavirus Vaccine Failure Zambian Children</brief_title>
	<detailed_description>The study conduct Kamwala health facility Lusaka Maternal Child Health ( MCH ) antiretroviral therapy ( ART ) clinic well CIDRZ Kamwala Research Unit co-located . Kamwala catchment population 10,000 approximately 30 new infant present MCH month 6-14 week ( DPT-HiB-Hep ) immunisation rate 95 % . Mother-infant pair approach initial visit MCH study clinic assistant peer counsellor information study local language choice . Those generally interested invite research clinic close , detailed information motivate mother recruit take write informed consent process study nurse . For illiterate participant , independent , literate individual witness validate inform consent process . A specific log maintain show information date number invite study , reason refusal document . A senior research nurse , study nurse , clinical research assistant responsible informed consent enrolment procedure supervision investigator . A paediatrician available hands-on consultation need . Cohort Follow-up . Enrolled mother ask complete demographic behavioural questionnaire , participant locator form , undergo phlebotomy mechanical expression breast-milk enrolment visit determination anti-rotavirus IgG IgA ( serum breast-milk ) . Infants baseline anti-rotavirus IgA IgG antibody determine ascertain baseline exposure wild-type transplacental immunoglobulin follow second serum IgA determination one month follow completion rotavirus vaccination ( approximately 14-20 week ) . Infants follow quarterly in-clinic remainder study also make interim clinic visit child diarrhoea . At visit , child weigh , height measure , anthropometrics take , include skin fold subcutaneous body fat mid upper arm circumference . During symptomatic interim visit , assessment make disease severity ( Vesikari scale ) sample stool collect determination rotavirus antigen genotype rotavirus positive . The patient also send home diarrhoea diary complete follow two week . Following identification child severe gastroenteritis , age-matched control within cohort ( without recent gastroenteritis ) bring measurement Vitamin A serum zinc level . Children gastroenteritis treat accord national guideline ( per WHO Integrated Management Childhood Illness ) . If referral require , child referred outpatient clinic , serious case University Teaching Hospital . Study Procedures . Enrolled mother ask complete demographic behavioural questionnaire , participant locator form , undergo phlebotomy mechanical expression breast-milk enrolment visit determination anti-rotavirus IgG IgA ( serum breast-milk ) . Infants baseline anti-rotavirus IgA IgG antibody determine ascertain baseline exposure wild-type transplacental immunoglobulin follow second serum IgA determination one month follow completion rotavirus vaccination ( approximately 14-20 week ) . Infants follow quarterly in-clinic remainder study also make interim clinic visit child diarrhoea . At visit , child weigh , height measure , anthropometrics take , include skin fold subcutaneous body fat mid upper arm circumference.55-57 During symptomatic interim visit , assessment make disease severity ( Vesikari scale58 ) sample stool collect determination rotavirus antigen genotype rotavirus positive . The patient also send home diarrhoea diary complete follow two week . Following identification child severe gastroenteritis , age-matched control within cohort ( without recent gastroenteritis ) bring measurement Vitamin A serum zinc level . Children gastroenteritis treat accord national guideline ( per WHO Integrated Management Childhood Illness ) . If referral require , child referred outpatient clinic , serious case University Teaching Hospital . Laboratory Methods . 1 . Detection Rotavirus-specific IgA IgG occur ELISA . Detection rotavirus-specific IgA IgG occur ELISA . Briefly , procedure follow . Microplate well ( e.g. , Nunc Immuno I ) incubate purified viral antigen preparation , wash phosphate buffer saline Tween detergent ( PBS-T ) . Serum breast-milk sample dilute serially ( PBS-T contain 1 % bovine serum albumin ) incubate coat microplates 2 hour 37oC overnight 4oC . Microplates wash peroxidase-conjugated anti-human IgA IgG goat antibody ( Sigma Immunochemicals ) add . The reaction terminate H2SO4 , optical density measure EIA plate reader . All sample assay duplicate viral antigen control antigen . A test well consider positive optical density 450 nm , e.g. , great equal two time control . Specificity control include well contain control antigen incubate absence sample , sensitivity check include well contain viral antigen incubate presence sample know contain high titre particular rotavirus-specific immunoglobulin class . 2 . Detection Rotavirus Antigen occur Rotaclone ELISA . Stool sample test rotavirus ELISA ( Rotaclone® , Meridian Biosciences ) accord manufacturer 's specification . Briefly , sample bring room temperature dilute buffer saline 0.02 % thimerosol . Diluted sample enzyme conjugate incubate monoclonal antibody VP6 protein within Rotaclone microplate . Substrate buffer contain urea peroxide tetramethylbenzidine add , reaction terminate H2SO4 . Spectrophotometric determination result make measure absorbance 450 nm air blank . Specimens absorbance unit ( A450 ) great 0.150 consider positive . Those absorbance equal 0.150 consider negative . 3 Determination Rotavirus VP7 Genotype . Viral RNA extract 10 % suspension rotavirus antigen-positive faecal material PBS ( pH 7.0 ) use TRIzolTM Reagent ( GIBCO Life Technologies ) accord manufacturer 's protocol . Viral RNA take RT-PCR described earlier . Extracted viral RNA take nested PCR utilize primer complimentary 3 ' end viral RNA strand within gene segment 9 , encode viral protein 7 ( VP7 ) . These primer use first strand synthesis . Primer RVG9 six serotype-specific primer ( aBT1 , aCT2 , aET3 , aDT4 , aAT8 , aFT9 ) locate six variable region gene 9 correspond G-serotypes 1 , 2 , 3 , 4 , 8 9 , use second amplification . Briefly , 5 µl RNA 25 pmol primer Beg9 End9 denature 5 min 97°C cooled ice . Thereafter , 8 µl RT reaction mixture contain 1.5 µl 10X PCR buffer ( 500 mM KCl , 100 mM Tris-HCl ( pH 8.3 ) , 2 µl 25 mM MgCl2 , 2 µl 2.5 mM dATP , dCTP , dGTP dTTP , 10 U AMV reverse transcriptase ( Promega ) 20 U Rnasin ribonuclease inhibitor ( Promega ) , add sample-primer mixture incubate 42°C 60 min . PCR buffer mixture ( 35 µl ) , contain 3.5 µl 10X PCR buffer , 2 µl 2.5 mM peach dATP , dCTP , dGTP dTTP , 2.5 U Ampli Taq DNA polymerase ( Perkin Elmer ) 27 µl water add RT reaction . The reaction mixture denature 94°C 3 min , follow 30 cycle ( 1 min 94°C , 2 min 42°C , 3 min 72°C ) final extension 5 min 72°C . First-round PCR product ( 2 µl ) transfer 48 µl second PCR reaction mixture , contain 5 µl 10X PCR buffer , 25 pmol primer aBT1 , aCT2 , aET3 , aDT4 , aAT8 , aFT9 RVG9 , 0.2 mM dATP , dGTP , dCTP dTTP , 2mM MgCl2 , 2.5 U Taq polymerase . Second-round cycling condition identical first round , except 25 cycle run . The PCR product analyze gel electrophoresis identify expect length amplify VP7 , allow determination genotype . Other primer set , PCR condition and/or sequence use distinguish genotype when/if initial primer fail . 4 Determination VP4 Genotype . The strategy PCR type gene 4 identical , principle , use VP7.64 First strand synthesis ( reverse transcription ) take advantage highly conserve area VP4 utilize primer Con2 Con3 ( Box 3 ) , complimentary 3 ' end viral RNA strand within gene segment 4 . 1 5 µL viral RNA add 0.5 ml microcentrifuge tube contain 3.5 µl dimethylsulfoxide ( Sigma ) final volume 8.5 µl , sample mix denature 97°C 5 min . The sample cool ice 5 min collect brief centrifugation . 13.5 µL H20 , 16 µL deoxynucleoside triphosphates ( 1.25 mM dATP , dGTP , dCTP , dTTP ) , 5 µL 1OX buffer ( 100 mM Trishydrochloride [ pH 8.3 ] , 500 mM KCl ) ( Perkin-Elmer Cetus ) , 3.5 µL 25 mM MgCl2 , 2 µl primer ( contain 25 µM primer , Con 2 Con 3 ) , 9 U reverse transcriptase add denatured dsRNA sample tube ( give final reaction volume 49 µ1 ) incubate 42oC 60 minute . Following addition 1 µL ( 1.9U ) Taq polymerase 100 µL mineral oil , first-round PCR carry 30 cycle ( 1 min 94oC , 2 min 50oC , 2 min 72oC . A cooling cycle use bring sample 17OC completion experiment . The second-round typing reaction perform use 0.5 5 µL first-round product ( 5 µL visible product ; 0.5 µL visible product ) mix 45 µL reaction mixture final volume 50 µL . If less 5 µL first round product add , remain volume , complete 50 µL , 10mM TrisHCl ( pH 8.3 ) -2.5mM MgCl¬2 . The reaction mixture 19.5 µL water , 16 µL dNTPs , 5 µL 10X Buffer II , 3 µL 25 mM MgCl2 , 1 µL primer cocktail ( contain 20 µM Con3 , 1T-1 , 2T-1 , 3T-1 , 4T-1 ) , 0.5 µL ( 2.5U ) Taq . The sample overlay mineral oil take 25 round PCR ( cycle first round ) . The sample analyze gel electrophoresis product size enable determination VP4 genotype . Other primer set and/or sequence use distinguish genotype when/if initial primer fail . 5 Determination Vitamin A Zinc level : Serum sample evaluate Vitamin A level ELISA ( e.g. , Human Vitamin A , EIAAB ) accord manufacturer 's instruction . Briefly , microtitre plate provide kit pre-coated antibody specific Vitamin A . Standards sample added appropriate microtitre plate well biotin-conjugated polyclonal antibody preparation specific VA Avidin conjugate Horseradish Peroxidase ( HRP ) add microplate well incubate . Then tetramethylbenzidine substrate solution add well . Only well contain Vitamin A , biotin-conjugated antibody enzyme-conjugated Avidin exhibit change colour . The enzyme-substrate reaction terminate addition H2SO4 color change measure spectrophotometrically wavelength 450 nm . The concentration VA sample determine compare O.D . sample standard curve . Zinc level measure blood use assay Lampugnani 's simple colorimetric method use spectrophotometric method chromogen 4- ( 2-pyridylazo ) resorcinol sodium salt measure serum zinc concentration .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Mother willing participate voluntarily able provide sign informed consent ( witness case illiterate participant ) Infant eligible rotavirus vaccine immunization per national policy ( male female infant , 612 week old ) Mother willing undergo study procedure , include questionnaire , HIV counsel testing , CD4 testing , provide breast milk blood sample enrolment . Mother willing child undergo study procedure include fullcourse rotavirus vaccination , phlebotomy enrolment 1 month postrotavirus vaccination , presentation clinic collection stool sample infant diarrhoea . Plans remain resident area willing come schedule visit duration study . Contraindication rotavirus vaccination . Previous administration rotavirus vaccine child . Recent immunosuppressive therapy child ( include highdose systemic corticosteroid ) . History ever receive blood transfusion blood product , include immunoglobulin within last 6 month , mother child . Mother plan child move away study catchment area within next two year . Any condition deem study investigator pose potential harm participant jeopardize validity study result .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>15 Weeks</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Rotavirus</keyword>
	<keyword>Diarrhoea</keyword>
	<keyword>Dmmunisation</keyword>
	<keyword>Seroconversion</keyword>
	<keyword>Breastmilk</keyword>
	<keyword>HIV</keyword>
	<keyword>Zinc</keyword>
	<keyword>Vitamin A</keyword>
	<keyword>Failure</keyword>
</DOC>